<DOC>
	<DOCNO>NCT00471211</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability efficacy 2 dos PBT2 administer 12 week compare placebo patient early Alzheimer 's disease treat acetylcholinesterase inhibitor .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability Efficacy PBT2 Patients With Early Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>diagnosis probable early Alzheimer 's disease stable dose acetylcholinesterase inhibitor community dwell stable medical condition unstable significant medical condition recurrent major psychiatric disorder treatment memantine</criteria>
	<gender>All</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>